Abstract

Lysine acetylation is a post-translational modification that is conserved from bacteria to humans. It is catalysed by the activities of lysine acetyltransferases, which use acetyl-CoA as the acetyl-donor molecule, and lysine deacetylases, which remove the acetyl moiety. Recently, it was reported that YcgC represents a new prokaryotic deacetylase family with no apparent homologies to existing deacetylases (Tu et al., 2015). Here we report the results of experiments which demonstrate that YcgC is not a deacetylase.

Data availability

All data generated or analyses during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Magdalena Kremer

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Kuhlmann Nora

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Marius Lechner

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Linda Baldus

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Michael Lammers

    Institute for Genetics, CECAD Research Center, University of Cologne, Cologne, Germany
    For correspondence
    michael.lammers@uni-koeln.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4168-4640

Funding

Deutsche Forschungsgemeinschaft (LA 2984/3-1)

  • Michael Lammers

Deutsche Forschungsgemeinschaft (CECAD)

  • Magdalena Kremer
  • Kuhlmann Nora
  • Marius Lechner
  • Linda Baldus
  • Michael Lammers

Boehringer Ingelheim Fonds (Exploration Grant)

  • Kuhlmann Nora

Deutsche Forschungsgemeinschaft (Cologne Graduate School of Ageing Research)

  • Magdalena Kremer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2018, Kremer et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,329
    views
  • 132
    downloads
  • 10
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Magdalena Kremer
  2. Kuhlmann Nora
  3. Marius Lechner
  4. Linda Baldus
  5. Michael Lammers
(2018)
Comment on "YcgC represents a new protein deacetylase family in prokaryotes"
eLife 7:e37798.
https://doi.org/10.7554/eLife.37798

Share this article

https://doi.org/10.7554/eLife.37798

Further reading

    1. Biochemistry and Chemical Biology
    2. Stem Cells and Regenerative Medicine
    Alejandro J Brenes, Eva Griesser ... Angus I Lamond
    Research Article

    Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.